🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

American Well Corp executive sells shares worth $507

Published 07/02/2024, 04:58 PM
AMWL
-

American Well Corp's (NYSE:AMWL) Chief Accounting Officer, Paul Francis McNeice, recently sold shares of the company's stock, totaling approximately $507. The transaction was executed on July 1, 2024, at a price of $0.3036 per share.

The shares sold by McNeice were part of an automatic "sell to cover" transaction, which is typically utilized to pay for the tax liability associated with the vesting of restricted stock units. According to the details provided in the SEC filing, this sale was not a discretionary trade by McNeice but a necessary step to fulfill tax obligations.

Following the sale, McNeice still holds a substantial amount of American Well Corp's stock, with 193,611 shares remaining in his possession. This indicates a continued vested interest in the company's performance and growth, despite the recent transaction to cover tax liabilities.

American Well Corp, which is incorporated in Delaware and headquartered in Boston, Massachusetts, operates within the business services sector. The company's Class A Common Stock is traded on the New York Stock Exchange under the ticker symbol AMWL.

Investors often monitor insider transactions as they can provide insights into executives' perspectives on the company's value and future prospects. However, in this case, the transaction was related to tax obligations rather than a reflection of the executive's outlook on the company's financial health.

The details of the transaction were made public through a Form 4 filing with the Securities and Exchange Commission, which is a requirement for officers, directors, and significant shareholders of public companies to report their trading activities.

In other recent news, American Well Corp, also known as Amwell, has reported a 7% decline in total revenue to $59.5 million for the first quarter of 2024. However, the company is forecasting revenue growth and improved adjusted EBITDA for 2025, driven by a shift towards subscription software. In line with these developments, Piper Sandler has maintained a neutral stance on Amwell, emphasizing the need for stabilization in subscription revenue and clearer signs of the company's projected return to double-digit growth in 2025.

On the governance front, shareholders have approved several key proposals including the election of directors, ratification of the company's independent auditor, executive compensation, and a reverse stock split. In a significant leadership change, co-founder Roy Schoenberg will transition to become the Executive Vice Chairman of the company's Board of Directors, with his brother, Ido Schoenberg, taking over as the sole Chief Executive Officer. These are among the recent developments in Amwell's ongoing efforts to expand its presence within the healthcare solutions sector.

InvestingPro Insights

In light of American Well Corp's (NYSE:AMWL) recent insider stock sale by Chief Accounting Officer Paul Francis McNeice, it's valuable to consider the broader financial context in which this transaction occurred. According to InvestingPro, AMWL's market capitalization stands at a modest 88.6 million USD, reflecting a challenging period for the company.

An InvestingPro Tip points out that AMWL is in a position where its liquid assets exceed short-term obligations, which could provide some financial stability in the short term. However, this is juxtaposed with the company's significant cash burn, as AMWL is quickly depleting its cash reserves. This is a critical factor for investors to consider, as it may impact the company's ability to fund operations without seeking additional capital.

Additionally, AMWL's stock price has experienced a precipitous decline, with a one-year total return of -88.1%, indicating a significant loss in shareholder value. This could suggest a lack of investor confidence or broader market challenges impacting the company. Moreover, the company's price-to-book ratio as of the last twelve months stands at 0.18, which might attract value investors seeking undervalued stocks, although the company's profitability concerns, highlighted by a negative P/E ratio of -0.29, may give pause to potential investors.

For readers looking to delve deeper into the financial health and future prospects of American Well Corp, there are additional InvestingPro Tips available. There are currently 12 more tips that could provide valuable insights. To access these tips and more detailed analytics, consider using the coupon code PRONEWS24 to get up to 10% off a yearly Pro and a yearly or biyearly Pro+ subscription on InvestingPro.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.